Oral pharmaceutical composition with plant alkaloid for treatment of dependencies

A composition and alkaloid technology, which is applied in the direction of drug combination, medical preparations containing active ingredients, active ingredients of heterocyclic compounds, etc., can solve the problem of providing uniformity and solubility of alkaloids, and the difficulty of providing uniform content of alkaloids Sexuality, concealing the risk of overdose and other issues, to achieve the effect of improving product efficacy, reducing the risk of side effects, and reducing anxiety and fear
CN113194930APending Publication Date: 2021-07-30索非药剂有限公司
9 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
索非药剂有限公司
Publication Date
2021-07-30

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

This invention is related to an oral pharmaceutical composition that contains a cholinergic agent, a natural plant alkaloid in particular, selected from the group of lobeline, anabasine, cytisine, galantamine or their acceptable salts, in the form of tablets and capsules. The excipients of the developed oral composition include cellulose powder, calcium sulphate, silica colloidal and magnesium stearate, the total content of cellulose powder and calcium sulphate dihydrate being from 64,5 to 97,5 % of the mass of the dosage form and at least 90% of the alkaloid particles being < 100um. The oral composition contains also at least one biologically active amino acid selected from: L-carnitine, tryptophan or a combination of them. The oral composition according to this invention achieves uniform distribution of the active substance in the composition, as well as stability of the composition due to the included excipients selected so as to react to a minimum with the alkaloid to form the qualitative and quantitative related substances admissible for the pharmaceutical composition. The composition according to this invention is applicable in the treatment of dependency and addiction to nicotine, tobacco products and alcohol.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to an oral pharmaceutical composition, which contains a cholinergic agent, especially a natural plant alkaloid selected from the group consisting of cytisine, galanthamine, lobeline, Anabasine or an acceptable salt thereof, the oral pharmaceutical composition for the treatment of dependence and addiction to nicotine, tobacco products and alcohol. Background technique

[0002] Alcohol and nicotine, like all drugs, have the potential to create and maintain dependence. Through their direct effects on cells, including nerve cells and their transmission systems (so-called neurotransmitters - acetylcholine, dopamine, serotonin), a condition known as "dependency syndrome" occurs due to the systemic uptake of the relevant substances Conditions - physical and mental. The central and peripheral nervous systems (CNS and PNS) are among those organ systems in which alcohol and nicotine produce various and intense effects, leading to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More